New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
07:10 EDTNEONeoGenomics validates and launches new detection test for the CALR gene
NeoGenomics announced that it has validated and launched a new test for the detection of mutations in the calreticulin, or CALR, gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms for the first time at the annual meeting of the American Society of Hematology last month. Since then, findings on the CALR gene have been published in the three articles referenced below.
News For NEO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 22, 2015
17:57 EDTNEONeoGenomics raises Q4 EPS view to 1c-2c from 0c-1c, consensus 0c
Raises Q4 revenue view to $25M from $23.0M-$24.5M, consensus $23.59M.
January 21, 2015
09:19 EDTNEONeoGenomics shares defended at Craig-Hallum
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use